nevirapine (Cipla Ltd.)
Welcome to the PulseAid listing for the nevirapine drug offered from Cipla Ltd.. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla Ltd. |
NON-PROPRIETARY NAME: | nevirapine |
SUBSTANCE NAME: | NEVIRAPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-05-22 |
END MARKETING DATE: | 0000-00-00 |
nevirapine HUMAN PRESCRIPTION DRUG Details:
Item Description | nevirapine from Cipla Ltd. |
LABELER NAME: | Cipla Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2012-05-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53104-0166_e4fedf97-e2ce-4832-89dd-c9fd025b527f |
PRODUCT NDC: | 53104-0166 |
APPLICATION NUMBER: | ANDA077956 |
Other NEVIRAPINE Pharmaceutical Manufacturers / Labelers: